Skip to main content
padlock icon - secure page this page is secure

Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry

Buy Article:

$52.00 + tax (Refund Policy)

Romiplostim is a thrombopoietin‐mimetic peptibody for adult refractory chronic immune thrombocytopenia (ITP). We aimed to describe ITP patients receiving romiplostim, platelet counts and romiplostim usage in UK clinical practice.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: bleeding; idiopathic thrombocytopenic purpura; platelet; primary immune thrombocytopenia; romiplostim; thrombopoietin receptor agonists

Document Type: Research Article

Publication date: May 1, 2019

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more